Calidi Biotherapeutics Inc (CLDI)

$0.76 -0.03 (-4.39%)
Market Cap 5.66M
Revenue (ttm) 0.00
Net Income (ttm) -22.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.08
Volume 52,916
Avg Vol 82,336
Day's Range N/A - N/A
Shares Out 7.17M
Stochastic %K 39%
Beta 1.09
Analysts Sell
Price Target $10.00

Company Profile

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcino...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 794 9600
Fax: 858 794 9605
Address:
4475 Executive Drive, Suite 200, San Diego, United States
race2zero
race2zero Feb. 23 at 9:02 PM
$CLDI why? They have nothing, absolutely nothing going for them
0 · Reply
chickenugget
chickenugget Feb. 23 at 8:50 PM
$CLDI keep adding
0 · Reply
race2zero
race2zero Feb. 23 at 2:50 PM
$CLDI scam!
0 · Reply
race2zero
race2zero Feb. 23 at 2:15 PM
$CLDI why do you keep mentioning CLDI in this nonsense? Not a good look
0 · Reply
race2zero
race2zero Feb. 23 at 1:50 PM
$CLDI odds of hearing anything from failed CEO Eric Poma this week. 20,000-1
0 · Reply
NetworkNewsWire
NetworkNewsWire Feb. 20 at 8:30 PM
Cancer Stress Protein Enables Tumors to Evade the Immune System $CLDI https://ibn.fm/cRZ5b #biomedstocks #Cancer
0 · Reply
race2zero
race2zero Feb. 20 at 4:50 PM
$CLDI not without a reverse split. Scam company with a CEO that ran his last company into delisting and will eventually do that here. Fake offices and fake images on their website
0 · Reply
race2zero
race2zero Feb. 20 at 2:39 PM
$CLDI LMAO, should run hard now! They made a poster!
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 20 at 2:38 PM
$CLDI scans
0 · Reply
aafetygod
aafetygod Feb. 20 at 9:16 AM
$CLDI This stock has been completely forgotten. There's zero news, too. But it still has the potential to shoot up to the $3.X range.
1 · Reply
Latest News on CLDI
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference

Feb 20, 2026, 8:00 AM EST - 3 days ago

Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference

Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference

Feb 12, 2026, 8:00 AM EST - 11 days ago

Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

Nov 17, 2025, 8:00 AM EST - 3 months ago

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights

Nov 13, 2025, 4:15 PM EST - 3 months ago

Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

Aug 21, 2025, 6:33 PM EDT - 6 months ago

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

Aug 20, 2025, 9:15 AM EDT - 6 months ago

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

Aug 8, 2025, 4:15 PM EDT - 7 months ago

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

Jul 25, 2025, 4:45 PM EDT - 7 months ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24

Jul 22, 2025, 8:00 AM EDT - 7 months ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Jul 10, 2025, 8:30 AM EDT - 8 months ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Jul 9, 2025, 2:01 PM EDT - 8 months ago

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Jul 8, 2025, 8:30 AM EDT - 8 months ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Jun 27, 2025, 8:00 AM EDT - 8 months ago

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Apr 25, 2025, 8:00 AM EDT - 10 months ago

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds

Apr 16, 2025, 9:30 AM EDT - 11 months ago

Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds

EGLE

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 31, 2025, 4:30 PM EDT - 11 months ago

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 28, 2025, 9:00 AM EDT - 11 months ago

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Mar 10, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Feb 28, 2025, 9:00 AM EST - 1 year ago

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

OSTX

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Feb 24, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5

Jan 29, 2025, 8:00 AM EST - 1 year ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Jan 28, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Jan 10, 2025, 4:30 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Jan 10, 2025, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Proposed Public Offering

Jan 8, 2025, 4:01 PM EST - 1 year ago

Calidi Biotherapeutics Announces Proposed Public Offering

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Nov 15, 2024, 4:05 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

Nov 14, 2024, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Nov 12, 2024, 5:29 PM EST - 1 year ago

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Oct 25, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

NXL

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Oct 23, 2024, 8:31 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

Oct 18, 2024, 11:00 PM EDT - 1 year ago

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Oct 18, 2024, 8:45 AM EDT - 1 year ago

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GRRR

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

Aug 13, 2024, 5:37 PM EDT - 1 year ago

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Aug 2, 2024, 9:00 AM EDT - 1 year ago

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GP

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

Jul 29, 2024, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

Jul 18, 2024, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

Jul 16, 2024, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

Calidi to Effect Reverse Stock Split

Jul 5, 2024, 4:15 PM EDT - 1 year ago

Calidi to Effect Reverse Stock Split

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

Jun 27, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

Jun 11, 2024, 4:05 PM EDT - 1 year ago

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

Jun 10, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting

Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

May 31, 2024, 8:51 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

May 17, 2024, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

UMAC

Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results

May 14, 2024, 4:05 PM EDT - 1 year ago

Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

May 1, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

race2zero
race2zero Feb. 23 at 9:02 PM
$CLDI why? They have nothing, absolutely nothing going for them
0 · Reply
chickenugget
chickenugget Feb. 23 at 8:50 PM
$CLDI keep adding
0 · Reply
race2zero
race2zero Feb. 23 at 2:50 PM
$CLDI scam!
0 · Reply
race2zero
race2zero Feb. 23 at 2:15 PM
$CLDI why do you keep mentioning CLDI in this nonsense? Not a good look
0 · Reply
race2zero
race2zero Feb. 23 at 1:50 PM
$CLDI odds of hearing anything from failed CEO Eric Poma this week. 20,000-1
0 · Reply
NetworkNewsWire
NetworkNewsWire Feb. 20 at 8:30 PM
Cancer Stress Protein Enables Tumors to Evade the Immune System $CLDI https://ibn.fm/cRZ5b #biomedstocks #Cancer
0 · Reply
race2zero
race2zero Feb. 20 at 4:50 PM
$CLDI not without a reverse split. Scam company with a CEO that ran his last company into delisting and will eventually do that here. Fake offices and fake images on their website
0 · Reply
race2zero
race2zero Feb. 20 at 2:39 PM
$CLDI LMAO, should run hard now! They made a poster!
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 20 at 2:38 PM
$CLDI scans
0 · Reply
aafetygod
aafetygod Feb. 20 at 9:16 AM
$CLDI This stock has been completely forgotten. There's zero news, too. But it still has the potential to shoot up to the $3.X range.
1 · Reply
race2zero
race2zero Feb. 19 at 4:39 PM
$CLDI I feel sorry for whoever accidentally bought over .80 today and especially over .90
0 · Reply
E8000
E8000 Feb. 19 at 2:13 PM
$CLDI
0 · Reply
race2zero
race2zero Feb. 19 at 1:44 PM
$CLDI did you look at the event schedule? They aren’t on it.
0 · Reply
E8000
E8000 Feb. 18 at 7:10 PM
$CLDI
0 · Reply
race2zero
race2zero Feb. 17 at 11:44 PM
$CLDI has nothing to do with CLDI
0 · Reply
NetworkNewsWire
NetworkNewsWire Feb. 17 at 8:35 PM
Existing Cancer Drug Shows Potential in Reactivating Immunotherapy $CLDI https://ibn.fm/eBt6U #tinygems #stocks
0 · Reply
race2zero
race2zero Feb. 17 at 5:17 PM
$CLDI off to another great start this week. Let’s go Eric Poma, file for bankruptcy already!
0 · Reply
race2zero
race2zero Feb. 17 at 2:25 PM
$BIVI $CLDI $MNDR $NOTE $SEGG only catalyst for $CLDI is bankruptcy coming
0 · Reply
EmproX
EmproX Feb. 16 at 11:37 PM
|~| $IVP $BAOS $CLDI $KITT |~|
0 · Reply
BigTimePennyStocks
BigTimePennyStocks Feb. 16 at 11:12 PM
Small-Caps with Catalysts this week: 👇👇 ( $SEGG, $CLDI, $NOTE, $BIVI, $MNDR, etc...) #NASDAQ #NYSE
0 · Reply
race2zero
race2zero Feb. 13 at 4:46 PM
$CLDI live look at the CLDI offices
0 · Reply
race2zero
race2zero Feb. 13 at 12:17 AM
$CLDI getting my signs ready for the conference in San Diego
0 · Reply